Clinical TrialID 7784
Role of Ashwagandha Extract (Capsule KSM-66 300 mg) in Improving Sexual Health in Healthy Men
NCT05840731
Sexual Health
Relationship Network
Interactive first-hop connections across herbs, ingredients, formulas, targets, diseases, symptoms, syndromes, evidence, and monographs.
Click a node to open it in a new tab
Trial: 1Herb: 1Links: 1
Arranging relationship network...
Record Fields
Scalar fields from the final clinical_trial record.
- Clinical Trial Id
- 7784
- Evidence Id
- 7784
- Core Evidence Id
- 7784
- Source Clinical Trial Id
- 7777
- Herb2 Clinical Trial Id
- HBCT007777
- Nct Id
- NCT05840731
- Title
- Role of Ashwagandha Extract (Capsule KSM-66 300 mg) in Improving Sexual Health in Healthy Men
- Status
- Recruiting
- Phase
- Phase 4
- Study Result
- No
- Study Condition
- Sexual Health
- Study Type
- Interventional
- Study Design
- Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (PARTICIPANT, INVESTIGATOR)|Primary Purpose: SUPPORTIVE_CARE
- Intervention
- DIETARY_SUPPLEMENT: Ashwagandha|OTHER: Placebo
- Intervention Allocation
- Randomized
- Intervention Model
- Parallel
- Intervention Mask
- Double
- Intervention Purpose
- Supportive_Care
- Gender
- Male
- Age
- Adult
- Enrollment
- 45
- Outcome Measure
- Number of Satisfying Sexual Events (SSEs), All enrolled subjects will be asked about SSEs 4 weeks prior Visit 1, Screening Visit/ Enrolment Visit/ Baseline Visit, (Day 1) and then throughout the study. It will include subject's inputs for number of intercourse and non-intercourse sexual events, number of orgasms, level of sexual desire, and satisfying sexual activity experienced. The subjects will be asked to mark a score for their sexual desire. They will be asked, "Indicate your most intense level of sexual desire in the last 24 hours/since your last visit." Potential responses included "no," "low," "moderate," or "strong", scored 0-3 (0 indicating no desire and 3 indicating the highest level of desire): 0 = No desire 1. = Low desire 2. = Moderate desire 3. = Strong desire Number of SSEs at Visit 3-End of study visit, (Week 8), will be compared with that of Screening Visit/ Enrolment Visit/ Baseline Visit, (Day 1), and Visit 2 (Week 4)., 8 weeks
- Sponsor Collaborator
- SF Research Institute, Inc.
- Funded By
- NETWORK
- Location
- San Francisco Research Institute, San Francisco, California, 94127, United States
- Other Id
- Ixoreal-MSD-CT-01-22
- Start Date
- 2023-08-07
- Primary Completion Date
- 2023-10-05
- Completion Date
- 2023-10-12
- First Posted
- 2023-05-03
- Results First Posted
- Last Update Posted
- 2023-05-09
- Study Document
- Study Url
- https://clinicaltrials.gov/study/NCT05840731
- Title Cn
- Title En
- Role of Ashwagandha Extract (Capsule KSM-66 300 mg) in Improving Sexual Health in Healthy Men
- Bilingual Status
- semi_complete